| 发明名称 |
COMPOSITION AND DOSAGE FORM FOR SUSTAINED EFFECT OF LEVODOPA. |
| 摘要 |
<p>The present invention encompasses compositions for the treatment of ParkinsonaCOEs disease comprising a therapeutically effective amount of levodopa or a metabolic precursor thereof and at least one dopamine transport inhibitor in sufficient amount to decrease dopamine degradation, wherein the dopamine transport inhibitor is administered to avid dyskinesia.</p> |
| 申请公布号 |
MXPA06004327(A) |
申请公布日期 |
2007.01.26 |
| 申请号 |
MX2006PA04327 |
申请日期 |
2004.10.14 |
| 申请人 |
TEVA PHARMACEUTICAL INDUSTRIES LTD. |
发明人 |
E. ITZHAK LERNER;VERED ROSENBERGER;MOSHE FLASHNER-BARAK |
| 分类号 |
A61P25/28;A61K31/135;A61K31/137;A61K31/198;A61K31/445;A61K31/4458 |
主分类号 |
A61P25/28 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
